Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 -1.59%53 Forward PE Ratio is 0.00 as of Aug. 25, 2026. GuruFocus rates TSE:6029 with a GF Score™ of 53/100 and a GF Value™ of 円116.11 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 316 Healthcare Providers & Services companies, Artra Group ranks worse than 316455.38% on this metric.
Artra Group (TSE:6029) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Artra Group Forward PE Ratio Related Terms
Artra Group Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Artra Group's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group Forward PE Ratio Chart
Artra Group Annual Data
Trend
Forward PE Ratio
Artra Group Quarterly Data
Forward PE Ratio
TSE:6029 vs HCA, THC, DVA: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Artra Group's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Artra Group's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Artra Group (TSE:6029) has a Forward PE Ratio of 0.00 as of Aug. 25, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Artra Group and its competitors. According to the industry distribution chart, Artra Group ranks #999999 out of 316 companies in the Healthcare Providers & Services industry.
Is Artra Group's Forward PE Ratio too high?
Artra Group's current Forward PE Ratio is 0.00. Based on the distribution chart, Artra Group ranks #999999 out of 316 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Artra Group has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #999999 out of 316 companies for Forward PE Ratio. This places Artra Group in the lower half of its industry. The industry median Forward PE Ratio is 18.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.81, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円116.11, compared to a current price of 円186.00 — trading 60.2% above its estimated fair value. The current Forward PE Ratio is 0.00. Artra Group's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Forward PE Ratio is 0.00 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円186.00 is trading 60.2% above its estimated GF Value™ of 円116.11.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Forward PE Ratio: 0.00
GF Value™: 円116.11 vs. price of 円186.00 (60.2% above fair value)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
53GF Score
Get the complete analysis for TSE:6029
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
